Institutional investors purchased a net $16.3 million shares of ZIOP during the quarter ended March 2015 and now own 42.17% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 171.5 Thousand shares of ZIOPHARM Oncology Inc